Mayer Arie bought ORMP
December 31, 2025 · Form 4 insider transaction
Mayer Arie bought 4,900 shares of Oramed Pharmaceuticals Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,900
Price
N/A
Total value
N/A
InsiderMayer Arie
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateDecember 31, 2025
Filing dateJanuary 5, 2026
Shares owned after168,009
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents RSUs. The RSUs will vest in quarterly installments over a one-year period starting April 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer.